How Much Does Chemotherapy for uterine cancer Cost in Republic of Korea?
Chemotherapy for uterine cancer in the Republic of Korea typically costs from $6,500 to $12,500. Final pricing depends on the drug regimen, cancer stage, and whether treatment is inpatient or outpatient. Patients save approximately 59% compared to the US average of $23,000. Standard services include oncologist consultations, intravenous drug administration, and routine blood monitoring.
- Hospital tier: Prices at premier Seoul centers often run 15-20% higher than regional facilities.
- Drug type: Targeted therapies or immunotherapies significantly increase costs compared to standard cytotoxic drugs.
- Diagnostic workups: PET-CT scans and biopsies are typically billed separately from the chemotherapy cycle fee.
- Inpatient stay: Some protocols requiring overnight monitoring for safety add room and nursing care charges.
Bookimed Expert Insight: Choosing a digital-first facility like Seoul National University Bundang Hospital (SNUBH) offers high-tech monitoring. Their BESTcare safety system reduces errors during complex drug administration. For those prioritizing survival stats, SNUH reports breast cancer outcomes exceeding US averages. Severance Hospital is ideal for complex cases due to its partnership with MD Anderson. These affiliations ensure international-standard protocols at South Korean prices. Most major clinics in Seoul also provide personal coordinators for overseas patients.
| Republic of Korea | Turkey | Austria | |
|---|---|---|---|
| Chemotherapy for uterine cancer | ≈ $6,500 | from $3,000 | ≈ $5,500 |
Your Benefits and Guarantees with Bookimed
Transparent Prices & Flexible Installments
No hidden fees – just official clinic prices. Pay at the clinic for Chemotherapy for uterine cancer upon arrival and use a flexible installment plan if needed.
Verified Clinics & Doctors Only
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Chemotherapy for uterine cancer and have the necessary licenses to serve international patients worldwide.
Free 24/7 Assistance
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Chemotherapy for uterine cancer journey.

Your personal Bookimed medical coordinator
- Supports you at every stage
- Helps choose the right clinic and doctor
- Ensures quick and convenient access to information
Discover the Best Chemotherapy for uterine cancer Clinics in Republic of Korea: 6 Verified Options and Prices
Chemotherapy for uterine cancer Overview in Republic of Korea
- Chemotherapy - from $1,900This therapy treats cancer by using drugs to destroy cancer cells and prevent their growth.
- Hyperthermic Intraperitoneal Chemotherapy (HIPEC) - from $18,000The operation heats chemotherapy drugs and applies them directly inside the belly to kill hidden cancer cells.
- Chemotherapy for liver cancer - from $3,000This therapy targets and kills cancer cells in the liver, using drugs given by mouth or injection.
- Chemotherapy for lung cancer - from $1,500This therapy utilizes drugs to kill lung cancer cells, often given via injection or oral tablet, enhancing survival rates.
- Chemotherapy for breast cancer - from $3,000This therapy targets and destroys breast cancer cells, using powerful drugs, enhancing survival and recovery rates.
Day 1 - Arrival
- Arrive at the hospital for admission.
- Complete necessary paperwork and discuss payment options.
- Settle into your room and prepare for pre-operative consultations.
Day 2 - Pre-Operation
- Consult with specialists: oncologist, gynecologist, and anesthesiologist.
- Undergo necessary medical tests: blood tests, CT scan, MRI.
- Review your medical history and current health status.
- Discuss and understand the Chemotherapy process and potential side effects.
Day 3 - Chemotherapy
- Arrive at the treatment room.
- Receive IV line placement for Chemotherapy administration.
- Undergo Chemotherapy treatment. This may take 1-3 hours.
- No anesthesia necessary as Chemotherapy is not a surgical procedure.
Day 4 - Post-Treatment
- Rest and recover in your room.
- Monitor for any immediate side effects under the nurse"s supervision.
- Stay in the hospital for observation. This may last 24-48 hours.
Weeks 1-6 - Rehabilitation
- Follow-up with your oncologist for assessment and further treatment plans.
- Manage any side effects with prescribed medication and rest.
- Light activity such as walking is encouraged after week 2.
- Resume work, if well enough, after 4 weeks.
- Return to normal activities, including sport, after 6 weeks.
Please note that each patient"s experience with Chemotherapy varies. Always follow your healthcare provider"s advice.
- Bookimed deposit: $200 or €200.
- Clinic deposit: Pay a set percentage in advance.
Our Doctors
View all Doctors
Cho Byung Chul
The doctor is the Head of the Oncology Department, specializing in chemotherapy for lung cancer, head and neck cancer, and esophageal cancer. The focus is on utilizing new clinical drugs to improve treatment outcomes. With extensive experience in oncological therapies, the doctor is at the forefront of cancer treatment advancements.

Dong Hyeon Lee
Dr. Dong Hyeon Lee is a hematologist-oncologist at Ewha Womans University Medical Center in Seoul. He specializes in bone marrow transplantation, including alternate donor and mismatched transplants. Dr. Lee treats colon cancer, myeloma, and lymphoma. He is a member of multiple professional oncology societies.
- Holds a Ph.D. from Sungkyunkwan University College of Medicine.
- Performs bone marrow transplants for complex hematological conditions.
- Authored over 10 peer-reviewed research papers in oncology.
- Works at a JCI-accredited hospital ranked among the world's best by Newsweek.

Lee, Han-Byoel
The doctor is an expert in oncoplastic surgery and breast cancer, with extensive experience from prestigious institutions. The doctor holds an M.D. degree from Seoul National University College of Medicine and an M.S. degree in Surgery from the same institution. Additionally, the doctor earned a B.S. in biological sciences from the Korea Advanced Institute of Science and Technology (KAIST) and a Ph.D. in Surgery from Seoul National University Graduate School.
Video Stories from Bookimed Patients
Reviews about Bookimed: Discover Patients' Insights
All reviewsShare this content
Anna Leonova
FAQ about Chemotherapy for uterine cancer in Republic of Korea
What is the standard chemotherapy regimen for uterine cancer in Korea?
The standard chemotherapy regimen for uterine cancer in South Korea is the combination of paclitaxel and carboplatin. Adopted by the Korean Society of Gynecologic Oncology, this platinum-based therapy serves as the primary first-line treatment for advanced or recurrent endometrial cancer cases.
- First-line combination: Patients typically receive paclitaxel and carboplatin every 3 weeks for 6 cycles.
- Immunotherapy integration: Modern Korean protocols now include Dostarlimab (Jemperli) or Pembrolizumab (Keytruda) for advanced cases.
- Sarcoma variations: Uterine leiomyosarcoma often requires doxorubicin monotherapy or combination with ifosfamide or trabectedin.
- Precision additions: Clinics use genomic testing to integrate PARP inhibitors or bevacizumab for high-risk patients.
Bookimed Expert Insight: While many countries follow broad international protocols, major Seoul centers like Asan Medical Center and Severance Hospital leverage massive patient volumes to refine dosing. These JCI-accredited facilities often utilize the BESTcare digital system to minimize medication errors during complex multi-drug infusions. This high-tech infrastructure allows Korean oncologists to maintain aggressive schedules while keeping complication rates lower than global averages.
Patient Consensus: Patients report that while fatigue typically peaks around the 3rd week, Korean oncology teams prioritize early administration of anti-nausea medications. Many suggest tracking CA-125 levels weekly to ensure the treatment effectively targets the tumor from the first cycle.
Are advanced treatments like immunotherapy available?
Advanced immunotherapies like pembrolizumab are widely available in South Korea for treating uterine cancer. Specialized centers use these treatments for MSI-high or dMMR advanced endometrial cancers. Leading institutions integrate immune checkpoint inhibitors with traditional chemotherapy to improve outcomes for metastatic or recurrent cases.
- Available therapies: Immune checkpoint inhibitors and monoclonal antibodies are standard for advanced stages.
- Top institutions: Asan Medical Center and Severance Hospital offer comprehensive genomic tumor sequencing.
- Clinical eligibility: Access requires genetic testing for MSI, dMMR, or HER2 biomarkers first.
- Digital precision: Seoul National University Hospital uses fully digital systems to track treatment response.
Bookimed Expert Insight: Major Korean centers like Asan Medical Center handle over 2,500 inpatients daily. This massive volume translates to high proficiency in managing complex immunotherapy reactions. Patients should prioritize hospitals with Joint Commission International accreditation to ensure these high-cost biological drugs meet global safety standards.
Patient Consensus: Many patients recommend getting tumor sequencing early at top Seoul hospitals. They emphasize checking eligibility for compassionate use trials before starting standard chemotherapy protocols.
How long does the treatment typically last?
Chemotherapy for uterine cancer in the Republic of Korea typically follows a standard course of 3 to 6 months. Most protocols involve 6 cycles administered every 21 days at JCI-accredited centers like Severance Hospital or Ewha Womans University Medical Center to ensure recovery between sessions.
- Treatment cycles: Most stage 2 or 3 regimens require 6 cycles of carboplatin and paclitaxel.
- Cycle frequency: Patients receive intravenous infusions every 3 weeks to allow blood count recovery.
- Total duration: Standard adjuvant therapy concludes within 18 to 24 weeks following initial cancer surgery.
- Hospital stay: Korean digital hospitals often provide chemotherapy as outpatient or 1-night inpatient stays.
Bookimed Expert Insight: While US patients often face scheduling delays, data from Asan Medical Center shows significantly higher efficiency with 2,550 daily inpatients. This high volume allows for precise 21-day cycling without the common administrative gaps that can extend total treatment timelines beyond 6 months.
Patient Consensus: Patients emphasize tracking neuropathy symptoms early to avoid dose reductions that might extend the 4.5-month timeline. Many noted that Korean clinics facilitate faster scheduling than Western facilities, often completing 5 to 6 cycles within exactly 18 weeks.
Is robotic surgery used alongside chemotherapy?
Robotic surgery is frequently integrated with chemotherapy for uterine cancer treatment in South Korea to improve patient outcomes. This multimodal approach uses robotic precision for tumor removal or staging, followed by chemotherapy to target remaining cancer cells and reduce recurrence risks.
- Adjuvant therapy: Most patients undergo robotic surgery first, starting chemotherapy within 3 weeks.
- Neoadjuvant approach: Chemotherapy may precede robotic surgery to shrink bulky tumors for easier removal.
- Precision staging: Robotic systems allow accurate lymph node assessment, determining if chemotherapy is necessary.
- Faster recovery: Minimally invasive robotic techniques enable patients to begin chemotherapy cycles sooner.
Bookimed Expert Insight: Data from top Seoul centers like Asan Medical Center and Severance Hospital shows a clear trend: robotic surgery's reduced physical trauma directly impacts chemotherapy tolerance. Patients recovering in 1–2 weeks instead of 6 weeks maintain better nutritional status and immune strength, which are critical for completing full chemotherapy regimens without delays.
Patient Consensus: Patients often report that choosing the robotic approach made the transition to chemotherapy much easier. They felt physically ready for treatment faster and appreciated the microscopic incisions that healed quickly before their first infusion.
What are the top hospitals for this treatment in South Korea?
The top hospitals for uterine cancer chemotherapy in South Korea include Samsung Medical Center, Asan Medical Center, and SNUH. These Big Five institutions lead globally in oncology, offering advanced genomic profiling and high success rates within JCI-accredited facilities and specialized women-only centers.
- Samsung Medical Center: Ranked 3rd globally for oncology, providing personalized chemotherapy regimens for gynecological cancers.
- Asan Medical Center: Korea's largest hospital, performing over 65,000 annual operations with a multidisciplinary cancer team.
- Ewha Womans University: A specialized women-only medical center focusing on aesthetic results and minimally invasive approaches.
- Severance Hospital: Features hyper-specialized teams and compassionate care, integrating advanced anti-emetic protocols for patients.
Bookimed Expert Insight: While Asan and Samsung lead in volume, Ewha Womans University Medical Center offers a unique advantage for uterine cancer patients. As a dedicated women's facility, they prioritize scarring concerns by utilizing specialized small-incision techniques even for complex oncological cases. This focus on aesthetic recovery is a differentiator rarely found in the larger, high-traffic general hospitals.
Patient Consensus: Patients frequently highlight the effectiveness of hospital-provided herbal medicine and acupuncture in Korea to manage chemotherapy-induced nausea. Travelers should use the private wings of major institutions to bypass administrative delays and secure faster treatment starts.
















